Amniotic Membrane Market Poised for Steady Growth, Reaching $1.7 Billion by 2030
Amniotic Membrane Market, by Product
What Is Amniotic Membrane?
Amniotic membrane (AM), or amnion, is a biological tissue from the innermost layer of the placenta. It has anti-inflammatory, anti-scarring, and regenerative properties, making it valuable in ophthalmology, wound care, and surgical applications.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/4559
Key Drivers of Market Growth
✅ Technological advancements in cryopreservation and lyophilization techniques
✅ Increased adoption in eye surgeries and wound care due to faster recovery times
✅ Rising geriatric population and prevalence of chronic wounds
✅ Growing awareness about biological grafts and their benefits
✅ Government initiatives to strengthen healthcare infrastructure in emerging nations
COVID-19 Impact: Temporary Slowdown, Long-Term Growth
While the COVID-19 pandemic disrupted elective procedures and wound care services, resulting in short-term setbacks, the demand for AM-based products is expected to bounce back strongly due to resumed surgeries and increased focus on tissue regeneration.
Market Segmentation Overview
🔬 By Product
Cryopreserved Amniotic Membrane
Dominated the market in 2020
Retains biological activity, widely used in visual and reconstructive surgeries
Lyophilized Amniotic Membrane
Expected to grow at the fastest rate
Easier storage, long shelf life, and fewer adverse reactions
🩺 By Application
Surgical Wounds (Leading Segment)
Benefits include scar reduction and accelerated healing
Ophthalmology
Widely used in ocular surface reconstruction
Others
Includes burns, chronic ulcers, and gynecological uses
🏥 By End User
Hospitals
Leading segment due to high patient footfall and surgical volumes
Ambulatory Surgical Centers & Specialized Clinics
Gaining traction with focus on outpatient procedures
🌍 By Region
North America
Largest market with strong research infrastructure
Expected to maintain dominance with 8.0% CAGR
Asia-Pacific
Fast-growing market due to aging population and expanding healthcare access
Europe & LAMEA
Steady growth expected, driven by increasing transplant procedures and innovation adoption
Competitive Landscape
Key players are focusing on product innovation, partnerships, and geographic expansion to strengthen their position. Leading companies include:
Allosure, Inc.
Amnio Technology, LLC
Applied Biologics LLC
Integra Lifesciences Holdings Corp.
MiMedx Group, Inc.
Skye Biologics Inc.
TissueTech, Inc.
Future Outlook
The amniotic membrane market holds significant potential, particularly in developing regions. Innovations in bioengineering, increased clinical trials, and a shift towards biological solutions in wound care and eye treatments will likely shape the market landscape in the years ahead.
Summary Bullet Points
📈 Market to grow from $1.1B in 2020 to $1.7B by 2030
👁️ Dominated by applications in surgical wounds and ophthalmology
❄️ Cryopreserved AM leads in usage; Lyophilized AM growing rapidly
🌐 North America leads, Asia-Pacific shows fastest potential
🏥 Hospitals remain the largest end users
🔬 Innovation and awareness are key growth levers
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/4559
David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
